ConvaTec Group (LON:CTEC)‘s stock had its “buy” rating reissued by equities research analysts at Peel Hunt in a research note issued on Thursday, ThisIsMoney.Co.Uk reports.
Other equities research analysts have also issued research reports about the stock. Barclays upped their target price on shares of ConvaTec Group from GBX 130 ($1.70) to GBX 185 ($2.42) and gave the stock an “equal weight” rating in a report on Friday, November 1st. Jefferies Financial Group upped their target price on shares of ConvaTec Group from GBX 145 ($1.89) to GBX 220 ($2.87) and gave the stock a “buy” rating in a report on Friday, November 29th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a GBX 171 ($2.23) target price (down previously from GBX 174 ($2.27)) on shares of ConvaTec Group in a report on Thursday, October 31st. UBS Group reaffirmed a “neutral” rating on shares of ConvaTec Group in a report on Monday, October 28th. Finally, Peel Hunt reaffirmed a “buy” rating and set a GBX 280 ($3.66) target price on shares of ConvaTec Group in a report on Friday, October 25th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and five have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of GBX 195.50 ($2.55).
Shares of LON CTEC opened at GBX 195.50 ($2.55) on Thursday. ConvaTec Group has a one year low of GBX 113.25 ($1.48) and a one year high of GBX 211.60 ($2.76). The firm has a market cap of $3.88 billion and a PE ratio of 24.44. The firm has a fifty day moving average of GBX 189.91 and a 200 day moving average of GBX 167.60. The company has a debt-to-equity ratio of 104.76, a quick ratio of 1.58 and a current ratio of 2.37.
About ConvaTec Group
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as for traumatic injury, burns, invasive surgery, and other causes.
Further Reading: What is an investor looking for in an SEC filing?
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.